BGI Group, founded in Beijing in 1999, is a leading global life sciences and genomics organization headquartered in Yantian. 

The company was established to represent China in the Human Genome Project (HGP), successfully completing 1% of the project as the only participating institution from a developing country.

BGI has since become a global leader in genomics, operating a network spanning over 100 countries and regions. Its core business centers on gene sequencing and downstream applications, including clinical diagnostics and precision medicine. The company is dedicated to its mission of “benefiting humanity through gene technology,” providing genomic solutions for reproductive health, cancer prevention and control, infectious disease monitoring, and chronic disease management.

Headquartered at the BGI Comprehensive Park in Yantian, BGI operates as a parent group with listed subsidiaries including BGI Genomics (stock code 300676) and MGI Tech, which manufactures clinical-grade gene sequencers. The company has established the BGI Science Education Hub in Yantian to promote public understanding of life sciences.